CIM vs. PFE
Compare and contrast key facts about Chimera Investment Corporation (CIM) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CIM or PFE.
Key characteristics
| CIM | PFE | |
|---|---|---|
| YTD Return | 10.09% | -1.52% |
| 1Y Return | 20.91% | -4.47% |
| 3Y Return (Ann) | -23.90% | -13.54% |
| 5Y Return (Ann) | -14.69% | -1.17% |
| 10Y Return (Ann) | 0.48% | 3.28% |
| Sharpe Ratio | 0.45 | -0.28 |
| Sortino Ratio | 0.87 | -0.24 |
| Omega Ratio | 1.11 | 0.97 |
| Calmar Ratio | 0.23 | -0.12 |
| Martin Ratio | 1.41 | -0.87 |
| Ulcer Index | 11.64% | 7.79% |
| Daily Std Dev | 36.64% | 24.18% |
| Max Drawdown | -89.69% | -54.82% |
| Current Drawdown | -60.91% | -50.04% |
Fundamentals
| CIM | PFE | |
|---|---|---|
| Market Cap | $1.24B | $151.42B |
| EPS | $3.36 | $0.75 |
| PE Ratio | 4.55 | 35.63 |
| PEG Ratio | -28.14 | 0.71 |
| Total Revenue (TTM) | $631.62M | $60.11B |
| Gross Profit (TTM) | $582.22M | $36.84B |
| EBITDA (TTM) | $607.64M | $15.48B |
Correlation
The correlation between CIM and PFE is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CIM vs. PFE - Performance Comparison
In the year-to-date period, CIM achieves a 10.09% return, which is significantly higher than PFE's -1.52% return. Over the past 10 years, CIM has underperformed PFE with an annualized return of 0.48%, while PFE has yielded a comparatively higher 3.28% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CIM vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Chimera Investment Corporation (CIM) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CIM vs. PFE - Dividend Comparison
CIM's dividend yield for the trailing twelve months is around 9.03%, more than PFE's 6.29% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CIM Chimera Investment Corporation | 9.03% | 14.03% | 20.36% | 8.55% | 13.66% | 9.73% | 11.22% | 10.82% | 14.34% | 14.08% | 17.61% | 11.61% |
PFE Pfizer Inc. | 6.29% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Drawdowns
CIM vs. PFE - Drawdown Comparison
The maximum CIM drawdown since its inception was -89.69%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for CIM and PFE. For additional features, visit the drawdowns tool.
Volatility
CIM vs. PFE - Volatility Comparison
Chimera Investment Corporation (CIM) has a higher volatility of 8.04% compared to Pfizer Inc. (PFE) at 4.31%. This indicates that CIM's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CIM vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Chimera Investment Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities